Beatrice Charreau
Overview
Explore the profile of Beatrice Charreau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goutaudier V, Sablik M, Racape M, Rousseau O, Audry B, Kamar N, et al.
Eur J Epidemiol
. 2024 Apr;
39(5):549-564.
PMID: 38625480
There is an unmet need for robust and clinically validated biomarkers of kidney allograft rejection. Here we present the KTD-Innov study (ClinicalTrials.gov, NCT03582436), an unselected deeply phenotyped cohort of kidney...
2.
Rousseliere A, Delbos L, Foureau A, Reynaud-Gaubert M, Roux A, Demant X, et al.
Front Immunol
. 2023 May;
14:1143875.
PMID: 37187736
Background: Human cytomegalovirus (HCMV) infection is common and often severe in lung transplant recipients (LTRs), and it is a risk factor associated with chronic lung allograft dysfunction (CLAD). The complex...
3.
Rousseliere A, Charreau B
Cells
. 2023 Mar;
12(6).
PMID: 36980230
This study investigated the frequency and peptide specificity of long-lasting HCMV-specific CD8 T cells in a cohort of 120 cytomegalovirus seropositive (HCMV+) healthy carriers with the aim of deciphering the...
4.
Rousseliere A, Gerard N, Delbos L, Guerif P, Giral M, Bressollette-Bodin C, et al.
Front Immunol
. 2022 Dec;
13:1063690.
PMID: 36532017
The human cytomegalovirus (HCMV) triggers both innate and adaptive immune responses, including protective CD8 αβT cells (CD8T) that contributes to the control of the infection. In addition to CD8T restricted...
5.
Charreau B
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35742847
The aim of this Special Issue is to provide an overview of recent investigations in the field of endothelial cell (EC) biology that advance our understanding of the molecular mechanisms...
6.
Lamarthee B, Burger C, Leclaire C, Lebraud E, Zablocki A, Morin L, et al.
J Am Soc Nephrol
. 2022 Feb;
32(12):3231-3251.
PMID: 35167486
Background: After kidney transplantation, donor-specific antibodies against human leukocyte antigen donor-specific antibodies (HLA-DSAs) drive antibody-mediated rejection (ABMR) and are associated with poor transplant outcomes. However, ABMR histology (ABMRh) is increasingly...
7.
Rousseliere A, Delbos L, Bressollette C, Berthaume M, Charreau B
Int J Mol Sci
. 2022 Jan;
23(1).
PMID: 35008688
HCMV drives complex and multiple cellular immune responses, which causes a persistent immune imprint in hosts. This study aimed to achieve both a quantitative determination of the frequency for various...
8.
Charreau B
Int J Mol Sci
. 2021 Aug;
22(15).
PMID: 34360735
As a cellular interface between the blood and tissues, the endothelial cell (EC) monolayer is involved in the control of key functions including vascular tone, permeability and homeostasis, leucocyte trafficking...
9.
Charreau B
Transplantation
. 2021 Mar;
105(11):e156-e167.
PMID: 33724240
Graft endothelial cell (EC) injury is central to the pathogenesis of antibody-mediated rejection (AMR). The ability of donor-specific antibodies (DSA) to bind C1q and activate the classical complement pathway is...
10.
Koenig A, Mezaache S, Callemeyn J, Barba T, Mathias V, Sicard A, et al.
J Am Soc Nephrol
. 2020 Nov;
32(2):479-494.
PMID: 33239394
Background: Binding of donor-specific antibodies (DSAs) to kidney allograft endothelial cells that does not activate the classic complement cascade can trigger the recruitment of innate immune effectors, including NK cells....